On March 17, the summary meeting of the clinical achievements of Sedum Lung Supplement Capsule was held in Hunan Occupational Disease Prevention and Control Hospital. Zeng Sanping, director of the Drug Registration Administration and Science and Technology Division of Hunan Provincial Food and Drug Administration, Lu Ming, secretary of the Party Committee of Hunan Occupational Disease Prevention and Control Hospital, Tan Yong, president, Deng Xiaobin, vice president, and Shuai Fangwen, chairman of Erkang Pharmaceutical and Limei Hospital, attended the meeting.
From November 2020 to November 2021, the one-year sedum lung capsule clinical project enrolled a total of 144 patients, and the technical team led by Xiao Xiongbin, chief physician of the Provincial Vocational Defense Hospital, formulated a professional and scientific clinical research plan. After one year of clinical systematic treatment and third-party data analysis, the project results show that Sedum Lung Capsule has an improving effect on lung function FEV1/FVC and dyspnea index, and the safety analysis of the drug has a good safety and has a good effect on the treatment of pneumoconiosis, COPD and other lung diseases. While significantly improving the respiratory function of the lungs, it can alleviate clinical symptoms such as cough, sputum cough, wheezing and shortness of breath and chest pain, and is suitable for clinical promotion and application of pneumoconiosis. In addition, its application to lung diseases such as COPD is also very promising.
At the meeting, Pan Pinhua, Luo Hong, and Chen Pingping experts from Xiangya Hospital of Central South University and the Second Xiangya Hospital agreed that the use of traditional Chinese medicine to treat pneumoconiosis in the sedum lung capsule project is very meaningful, the project plan design is scientific, the results are credible, providing patients with strict and credible diagnosis and good treatment methods, and also put forward valuable suggestions for further in-depth research of the project.
Zeng Sanping said that the Provincial Food and Drug Administration vigorously supports the development of traditional Chinese medicine special projects, and the Sedum Lung Capsule Project is a pioneering initiative in the treatment of occupational diseases, and the Provincial Food and Drug Administration encourages the project side to actively innovate and declare new drugs to the State Food and Drug Administration.
Tan Deming, director of the Occupational Health Department of the Provincial Health Commission, believes that the results of the Sedum Lung Capsule Project show that traditional Chinese medicine has a certain therapeutic effect on pneumoconiosis, and has a certain curative effect on the lung function and symptoms of patients, which fully shows that traditional Chinese medicine has great potential.
The Party Central Committee attaches great importance to the inheritance and development of China's excellent traditional medicine culture, and clearly proposes to "focus on promoting the revitalization and development of traditional Chinese medicine". The summary meeting of the results of Sedum Lung Capsules marked the complete success of the tripartite cooperation between Hunan Occupational Disease Prevention and Control Institute, Hunan Erkang Pharmaceutical Co., Ltd. and Liuyang Limei Hospital, and was also another milestone in the use of traditional Chinese medicine in Hunan Province to treat lung diseases such as pneumoconiosis, which is of long-term significance for Hunan Province to explore and share a new mechanism for the coordinated development of traditional Chinese and Western medicine, and to build a high-quality Chinese medicine service system integrating preventive health care, disease treatment and rehabilitation.
Liuyang Limei Hospital said that it will continue to vigorously develop the characteristic role of traditional Chinese medicine in the treatment of pneumoconiosis, COPD and other lung diseases together with the Hunan Provincial Vocational Defense Institute and Erkang Pharmaceutical, boost the high-quality development of the 100 billion biomedical industry in Hunan Province, and make more and more important contributions to the health of the people.